Ebiquity FY25 Results: Strategic Reshuffle Amid North America Challenges and £10m Goodwill Hit

Ebiquity FY25: revenue softer, profits squeezed, £10.0 million impairment – but cash flow improves

Ebiquity has posted FY25 results that land in line with January’s trading update. Revenue fell 4% to £73.4 million, adjusted operating profit dropped 42% to £4.6 million, and a £10.0 million non-cash impairment in North America dragged the Group to a statutory loss.

There is good news on cash and discipline. Free cash flow swung to a £3.1 million inflow, net debt reduced to £13.1 million, and management has tightened cost control, revamped leadership and pushed hard on proprietary tech and AI. The message is simple: 2025 was tough, the reset is done, and Ebiquity is aiming to return to growth.

Key numbers at a glance

Metric	FY25	FY24	Change
Revenue	£73.4m	£76.8m	-4%
Adjusted operating profit	£4.6m	£7.9m	-42%
Adjusted operating margin	6.3%	10.3%	-4.0pp
Adjusted profit before tax	£1.1m	£6.5m	-82%
Adjusted EPS	(1.39p)	3.17p	–
Statutory loss before tax	£(12.1)m	£(2.3)m	–
Free cash flow	£3.1m	£(2.6)m	+£5.7m
Net debt (excl. restricted cash)	£13.1m	£15.6m	£2.5m better
Impairment charge (North America)	£10.0m	£-	Non-cash

What drove the shortfall: regions and service lines

• Regions:
  • UK & Ireland up 5% to £33.0 million, with strong demand in Retail and Healthcare & Pharma.
  • Continental Europe down 6% to £19.8 million, a mixed picture with Italy up 35% and Portugal up 11% offset by France and Germany.
  • North America down 23% to £12.8 million, the main drag due to client delays and deferrals, particularly in Automotive, Retail and Travel & Hospitality.
  • APAC flat at £7.7 million, with growth in Transform offset by lower Govern revenue in China.
• Service lines:
  • Transform up 6% to £8.4 million, led by Agency Selection Management in UK&I and APAC.
  • Govern down 7% to £54.8 million, with Media Performance down 9% to £46.5 million, mostly North America related.
  • Contract Compliance up 7% to £8.3 million, reflecting healthy demand for compliance and governance services.
  • Grow broadly flat at £10.2 million, with late-year wins feeding 2026 momentum.
• Profitability by region on an adjusted basis: UK&I margin 25.3%, Continental Europe 15.9%, North America 8.0%, APAC 6.5%.

North America: the problem child and the plan

North America is the clear pain point: revenue down 22.8% and a £10.0 million impairment wiped out the region’s acquired goodwill. Management points to macro headwinds, elongated decision cycles and project deferrals. In response, Ebiquity appointed a new Managing Director for the Americas in June 2025, restructured the leadership team, broke down silos, and refocused on profitable client relationships.

The recovery narrative has early validation. Q1 2026 started “encouragingly” and the Group has secured marketing effectiveness engagements with an aggregate contract value of more than £10 million over three years. It is not a full turnaround yet, but commercial momentum matters after a bruising 2025.

Cash generation and debt: a welcome improvement

Despite lower profits, cash performance improved notably. Adjusted cash from operations rose to £12.8 million, helped by a £4.7 million working capital inflow. Free cash flow swung to a £3.1 million inflow, and net debt fell to £13.1 million from £15.6 million.

Banking flexibility has been reinforced. In April 2026, Ebiquity amended and extended its revolving credit facility to £28 million, maturing in October 2027, with SONIA plus a 2.75% to 3.35% margin depending on leverage. Covenants look calibrated to current trading. For a business resetting its cost base and targeting growth, this runway is useful.

Strategy reset, AI push and sharper commercial discipline

Leadership has been overhauled: new CFO, COO, MDs for Australia and the Americas, and fresh roles in 2026 for a Managing Director of Marketing Transformation and a Head of Growth, Americas. A new Staff Cost to Profit Conversion KPI was embedded into FY26 budgets to hard-wire profitability into engagements.

On technology, Ebiquity deployed ERAbot, a proprietary agentic AI assistant, to over three quarters of staff by end FY25 and now over 90%. The aim is higher productivity plus richer insights from the Media Data Vault, with more client-facing AI features and Total TV expansion planned for 2026. It is a sensible route to scale expertise without bloating headcount.

Order visibility and balance sheet

• Unsatisfied long-term contract value at year end: £18.4 million within one year and £1.2 million beyond a year.
• Net assets reduced to £24.0 million (2024: £35.8 million), mainly due to the North America impairment and amortisation of acquired intangibles.
• No dividend declared, as expected while the reset is underway.

Outlook and my view

The tone is cautiously upbeat. Management says decisive actions on leadership, operations and technology position the Group to return to growth. Q1 2026 trading was encouraging and the £10 million-plus of multi-year engagements provides some baseline activity. Equally, the ad market has been choppy, particularly in North America, and Ebiquity will need Q2 to firm up full-year visibility.

Positives: strong UK&I performance, Contract Compliance growth, improved cash generation, lower net debt, and a refocused North America with experienced leadership. Negatives: a sharp margin reset to 6.3%, statutory losses, and the credibility hit implied by a large impairment and halved share price in 2025. The job now is delivery.

What to watch in 2026

• North America recovery – revenue stabilisation and margin rebuild after the leadership changes.
• Adjusted operating margin – can 6.3% move decisively higher as cost discipline bites.
• Cash conversion – was the 2025 working capital inflow a one-off or a repeatable habit.
• Order intake – progression of the >£10 million three-year engagements and additional wins.
• AI and product roll-out – evidence of ERAbot and Total TV driving delivery efficiency and win rates.
• Capital markets day in June 2026 – clarity on the updated strategy, KPIs and medium-term targets.

Quick jargon buster

• Adjusted results – management’s view of underlying performance, excluding “highlighted items” such as amortisation of acquired intangibles, severance, acquisition/refinancing costs and impairments.
• Highlighted items – charges or credits shown separately to help explain underlying trading. In FY25 these totalled £13.2 million pre-tax, including the £10.0 million impairment in North America.
• Impairment – a non-cash write-down when the carrying value of assets exceeds recoverable value. It hurts reported profit but not cash.
• Free cash flow – cash from operations less capex, lease payments and loan fees. Ebiquity generated £3.1 million in FY25.
• Net debt – borrowings less cash (excluding restricted cash in Russia). End FY25: £13.1 million.

Bottom line

Ebiquity’s FY25 shows a business that took its medicine. The impairment and profit squeeze lay bare a difficult year, especially in North America. But the balance sheet is steadier, the leadership bench is deeper, and operational discipline has sharpened. If the early 2026 momentum carries through and margins rebuild, this reset could mark the trough. The next checkpoint is Q2 trading colour and June’s capital markets day.